Cargando…

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy

BACKGROUND: Inflammation is one of the most important characteristics of tumor tissue. Signatures based on inflammatory response-related genes (IRGs) can predict prognosis and treatment response in a variety of tumors. However, the clear function of IRGs in the triple negative breast cancer (TNBC) s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yangyang, Cen, Kenan, Yang, Shi, Mai, Yifeng, Hong, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311032/ https://www.ncbi.nlm.nih.gov/pubmed/37397391 http://dx.doi.org/10.3389/fonc.2023.1175000

Ejemplares similares

Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients
por: Cao, Jie, et al.
Publicado: (2023)

Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer
por: Cen, Kenan, et al.
Publicado: (2023)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
por: Schreier, Ashley, et al.
Publicado: (2023)

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer
por: Sun, Xiaoli, et al.
Publicado: (2021)

A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer
por: Chang, Yu-Tien, et al.
Publicado: (2022)

A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2022)

Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
por: Cai, Shuang-Long, et al.
Publicado: (2023)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
por: Li, Zhufeng, et al.
Publicado: (2023)

Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021)

Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA–lncRNA Signatures and Risk of Tumor Recurrence
por: Li, Jia-wei, et al.
Publicado: (2021)

Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer
por: Wang, Xin-Hua, et al.
Publicado: (2022)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
por: Wang, Daodu, et al.
Publicado: (2022)

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
por: Wang, Zhen, et al.
Publicado: (2021)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
por: Shan, Jingxuan, et al.
Publicado: (2019)

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
por: Chen, Li, et al.
Publicado: (2021)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Platinum-Based Chemotherapy and Immunotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis and Indirect Treatment Comparison
por: He, Qin, et al.
Publicado: (2021)

A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
por: Peng, Wenting, et al.
Publicado: (2021)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer
por: Zhan, Dandan, et al.
Publicado: (2023)

Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer
por: Pariyar, Mamta, et al.
Publicado: (2022)

Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study
por: Wang, Qifeng, et al.
Publicado: (2019)

Identification of a Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast Cancer
por: Liu, Yang, et al.
Publicado: (2021)

Construction of a neural network diagnostic model for renal fibrosis and investigation of immune infiltration characteristics
por: Guo, Yangyang, et al.
Publicado: (2023)

High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
por: Liu, Xinkui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jj7frvos63ta294b0ht33tejks